Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid. | JID Innov | 2025 | 41127641 | PubTator, text mining | PubMed |
| Characterization of antimicrobial resistant Empedobacter from fresh meat and meat preparations. | Curr Res Food Sci | 2025 | 41080801 | PubTator, text mining | PubMed |
| Case Report: Occupational bullous dermatosis: first report of skin lesions induced by PVC welding fume in a manufacturing worker. | Front Immunol | 2025 | 41080599 | PubTator, text mining | PubMed |
| Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases. | Front Immunol | 2025 | 41080589 | PubTator, text mining | PubMed |
| High-throughput electronic property prediction of cyclic molecules with 3D-enhanced machine learning. | Chem Sci | 2025 | 41064327 | PubTator, text mining | PubMed |
| In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target. | Nat Commun | 2025 | 41022734 | PubTator, text mining | PubMed |
| An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa. | Dent J (Basel) | 2025 | 41002671 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Cells | 2025 | 41002429 | PubTator, text mining | PubMed |
| Real-Time, Noninvasive Diagnosis of Bullous Pemphigoid: Diagnostic Performance of Line-Field Confocal Optical Coherence Tomography. | Skin Res Technol | 2025 | 40990140 | PubTator, text mining | PubMed |
| Tissue and systemic inflammation in dystrophic epidermolysis bullosa: a systematic review and meta-analysis. | Orphanet J Rare Dis | 2025 | 40988071 | PubTator, text mining | PubMed |
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol. | PLoS One | 2025 | 40971360 | PubTator, text mining | PubMed |
| Mechanical Stretch-Induced Interlayer Coordination between MMP2 and COL17A1 Exacerbates Regenerative Exhaustion in Skin. | Adv Sci (Weinh) | 2025 | 40960906 | PubTator, text mining | PubMed |
| Identifying novel genetic variants in epidermolysis Bullosa among Middle Eastern Arab Families: Insights from whole exome sequencing and computational analysis. | PLoS One | 2025 | 40956805 | PubTator, text mining | PubMed |
| Dupilumab monotherapy in super-elderly patients with bullous pemphigoid: a retrospective study on long-term efficacy and safety in mild to moderate cases. | J Dermatolog Treat | 2025 | 40931388 | PubTator, text mining | PubMed |
| Eosinophilic granulomatosis with polyangiitis complicated with bullous pemphigoid. | BMJ Case Rep | 2025 | 40930740 | PubTator, text mining | PubMed |
| Are the dermatological cut-off values of commercially available ELISAs for BP180-NC16A appropriate when applied for diagnosis of oral mucous membrane pemphigoid?. Results of a preliminary study. | Minerva Dent Oral Sci | 2025 | 40924034 | PubTator, text mining | PubMed |
| Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context. | Front Immunol | 2025 | 40918092 | PubTator, text mining | PubMed |
| Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma. | Sci Adv | 2025 | 40901948 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Effects of Long-Term Contact Lens Wearing on the Human Corneal Epithelium. | Invest Ophthalmol Vis Sci | 2025 | 40856653 | PubTator, text mining | PubMed |
| Localized variant of junctional epidermolysis bullosa with R795X mutation. | Dermatol Reports | 2025 | 40844377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=7